ZNF354B and inflammatory bowel disease: The mean IBD-KID2 scores between the baseline and repeat administrations were not significantly different (MD 0.3, P = 0.912) with a high ICC score (ICC = 0.851, P ≤ 0.005) thus establishing test–retest reliability for the target population of IBD-KID2.